Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan C Moss

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Inflammatory Bowel Diseases|September 6, 2014
Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational studyByron P Vaughn, Manuel Martinez-Vazquez, Vilas R Patwardhan, et al.
Inflammatory Bowel Diseases|November 29, 2016
Cutaneous Vasculitis in a Patient with Crohn's Disease Treated with AdalimumabDidia B Cury, Alexandre W S de Souza, Giovanni A Vianna, et al.
Nuclear Medicine Communications|January 14, 2012
Focal physiologic fluorodeoxyglucose activity in the gastrointestinal tract is located within the colonic lumenKe Wang, Yih-Chieh S Chen, Matthew R Palmer, et al.
Journal of Crohn'S & Colitis|March 27, 2019
DUBLIN [Degree of Ulcerative colitis Burden of Luminal Inflammation] Score, a Simple Method to Quantify Inflammatory Burden in Ulcerative ColitisCatherine R Rowan, Garret Cullen, Hugh E Mulcahy, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 27, 2024
Hot avulsion <i>versus</i> argon plasma coagulation for the management of the non-ensnarable polyp: A multicenter, randomized controlled trialChloe Attree, Ravinder Ogra, Ian F Yusoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2008
Melanin-concentrating hormone as a mediator of intestinal inflammationEfi Kokkotou, Alan C Moss, Daniel Torres, et al.
Cellular Immunology|May 21, 2013
Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitisDidia Bismara Cury, Sender Jankiel Mizsputen, Clara Versolato, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2008
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamstersEfi Kokkotou, Alan C Moss, Athanasios Michos, et al.
Inflammatory Bowel Diseases|January 20, 2020
Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial CellsJohn Gubatan, Gillian A Mehigan, Fernando Villegas, et al.
The American Journal of Gastroenterology|June 11, 2014
Attitudes to mesalamine questionnaire: a novel tool to predict mesalamine nonadherence in patients with IBDAlan C Moss, Yvonne Lillis, Jessica B Edwards George, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Inflammatory Bowel Diseases|September 6, 2014
Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational studyByron P Vaughn, Manuel Martinez-Vazquez, Vilas R Patwardhan, et al.
Inflammatory Bowel Diseases|November 29, 2016
Cutaneous Vasculitis in a Patient with Crohn's Disease Treated with AdalimumabDidia B Cury, Alexandre W S de Souza, Giovanni A Vianna, et al.
Nuclear Medicine Communications|January 14, 2012
Focal physiologic fluorodeoxyglucose activity in the gastrointestinal tract is located within the colonic lumenKe Wang, Yih-Chieh S Chen, Matthew R Palmer, et al.
Journal of Crohn'S & Colitis|March 27, 2019
DUBLIN [Degree of Ulcerative colitis Burden of Luminal Inflammation] Score, a Simple Method to Quantify Inflammatory Burden in Ulcerative ColitisCatherine R Rowan, Garret Cullen, Hugh E Mulcahy, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|March 27, 2024
Hot avulsion <i>versus</i> argon plasma coagulation for the management of the non-ensnarable polyp: A multicenter, randomized controlled trialChloe Attree, Ravinder Ogra, Ian F Yusoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2008
Melanin-concentrating hormone as a mediator of intestinal inflammationEfi Kokkotou, Alan C Moss, Daniel Torres, et al.
Cellular Immunology|May 21, 2013
Serum calprotectin levels correlate with biochemical and histological markers of disease activity in TNBS colitisDidia Bismara Cury, Sender Jankiel Mizsputen, Clara Versolato, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2008
Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamstersEfi Kokkotou, Alan C Moss, Athanasios Michos, et al.
Inflammatory Bowel Diseases|January 20, 2020
Cathelicidin Mediates a Protective Role of Vitamin D in Ulcerative Colitis and Human Colonic Epithelial CellsJohn Gubatan, Gillian A Mehigan, Fernando Villegas, et al.
The American Journal of Gastroenterology|June 11, 2014
Attitudes to mesalamine questionnaire: a novel tool to predict mesalamine nonadherence in patients with IBDAlan C Moss, Yvonne Lillis, Jessica B Edwards George, et al.
Pageof 14